Skip to main content
Clinical Trials/NCT05666154
NCT05666154RecruitingNot Applicable

Targeted Elimination Diet in FD Patients Following Identification of Trigger Nutrients Using Confocal Laser Endomicroscopy

Universitaire Ziekenhuizen KU Leuven1 site in 1 country65 target enrollmentStarted: December 5, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
65
Locations
1
Primary Endpoint
Responder rates in targeted diet vs sham diet

Study Overview

Brief Summary

After a thorough baseline evaluation, functional dyspepsia (FD) patients will be exposed to nutrients while undergoing confocal laser endomicroscopy (CLE). Patients presenting an acute mucosal reaction upon nutrient exposure will be instructed to exclude their respective trigger nutrient or a nutrient without mucosal reaction (=sham diet) from their diet for 4 weeks in a randomized, blinded crossover fashion.

The aim of the trial is to assess the symptomatic response to the targeted diet and further elucidate mechanisms underlying the acute mucosal reactions observed in CLE upon nutrient exposure.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Age 18-70 y/o (70 years included)
  • •Male or female subjects
  • •FD (PDS, EPS or overlap) according to Rome IV criteria
  • •Provide written informed consent to participate in the study
  • •Women of child-bearing potential agree to apply a highly effective method of birth control during the entire duration of the trial. Highly effective birth control is defined as those which result in a low failure rate (i.e., less than 1% per year) when used constantly and correctly such as implants, injectables, combined oral contraceptive method, or some intrauterine devices (IUDs), sexual abstinence, or vasectomized partner. Women of non-childbearing potential may be included if surgically sterile (tubal ligation or hysterectomy) or postmenopausal with at least 2 year without spontaneous menses.
  • •Subjects who are capable to understand the study and the questionnaires, and to comply with the study requirements.

Exclusion Criteria

  • •Pregnant or breastfeeding women
  • •History of major surgery of the gastrointestinal tract (cholecystectomy and uncomplicated appendectomy are allowed)
  • •Symptoms predominantly associated with irritable bowel syndrome or gastro-esophageal reflux disease
  • •IgE-mediated food allergies identified by immunocaps blood tests
  • •Known underlying organic gastrointestinal disease
  • •Current use of NSAIDs, proton-pump inhibitors, systemic histamine-receptor antagonists, mast cell stabilizers, corticosteroids, opioids (need to be stopped at least 2 weeks). Use of antibiotics in the past 6 weeks.
  • •Allergy to Fluorescein or Propofol
  • •Known celiac disease
  • •Following a diet, interfering with the study diet in opinion to the investigators

Arms & Interventions

Sham diet

Sham Comparator

Diet excluding a sham nutrient without acute mucosal reaction in CLE

Intervention: Sham diet (Other)

Real diet

Active Comparator

Diet excluding the trigger nutrient identified by an acute mucosal reaction in CLE

Intervention: Real diet (Other)

Wheat exclusion diet

Active Comparator

In patients without identified trigger nutrient (i.e. no acute mucosal reaction to any nutrient), wheat will be excluded as an empirical diet in crossover fashion with soy.

Intervention: Wheat exclusion diet (Other)

Soy exclusion diet

Active Comparator

In patients without identified trigger nutrient (i.e. no acute mucosal reaction to any nutrient), wheat will be excluded as an empirical diet in crossover fashion with soy.

Intervention: Soy exclusion diet (Other)

Outcomes

Primary Outcomes

Responder rates in targeted diet vs sham diet

Time Frame: After 4 weeks of dietary intervention

Response defined by an improvement of minimum 0.5 points on the LPDS scale

Secondary Outcomes

  • Baseline duodenal transepithelial electrical resistance between groups(At baseline)
  • Baseline duodenal flux of horse-radish peroxidase between groups(At baseline)
  • Evolution of duodenal flux of horse-radish peroxidase between dietary interventions(Baseline and after 4 weeks of diet)
  • Evolution of duodenal transepithelial electrical resistance between dietary interventions(Baseline and after 4 weeks of diet)
  • Baseline mucosal immune cell composition between groups(Baseline)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials